“…In 1994, a genetic link between APS-1 and genes located in 21q22.3 was identified, and subsequently the autoimmune regulator ( AIRE ) was conformed as the causative gene [ 6 , 7 ]. The overall prevalence of the disease is lower than 10/million population but a higher prevalence in historically isolated populations such as Iranian Jews (1/9,000), Sardinians (1/14,000), and Finns (1/25,000) and lower in Norwegians (1/80,000) and Poland (1/129,000), while scarce in East Asians [ 8 – 10 ]. Clinically, it is a highly variable disease manifested with autoimmunity primarily involved in endocrine organs (parathyroid, adrenals, thyroid, gonads, pituitary) and non-endocrine organs (skin, liver, kidney, lung, eye, intestine) [ 8 , 11 ].…”